FIELD: chemistry.
SUBSTANCE: invention relates to analytical chemistry. A method for controlling the content of anti-tuberculosis preparations (ATP) of the main line and their toxic metabolites in blood plasma involves preparation of blood plasma for chromatographic analysis by adding an antioxidant in form of ascorbic acid, precipitating proteins with an organic solvent, diluting the sample with deionized water at ratio of 1:10, performing analysis by reversed-phase liquid chromatography in a gradient elution mode, detecting ATP signals using a triple quadrupole tandem mass spectrometer with electrospray ionization, as controlled ATP pyrazinamide, isoniaside, ethambutol and rifampicin are determined, as toxic metabolites – pyrazine acid, 25-O-deacetyltrifampicin, acetyliso-niazine and isonicotinic acid, measuring analytical parameters of the analyzed sample and comparing them with analytical parameters of chromatographic analysis of the solution of ATP standards with known concentrations, qualitative and quantitative determination of ATP and their metabolites in blood plasma for monitoring of their tolerated doses.
EFFECT: what is presented is a method for monitoring the content of anti-tuberculosis preparations of the main line and their toxic metabolites in blood plasma.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
METHOD FOR TREATMENT OF PULMONARY ORGANS TUBERCULOSIS | 2005 |
|
RU2299068C2 |
DIAGNOSTIC TECHNIQUE FOR MEMBRANE-DESTRUCTIVE EFFECT OF ANTITUBERCULOUS CHEMOTHERAPY | 2019 |
|
RU2709504C1 |
PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
COMPOSITE PHARMACEUTICAL COMPOSITION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247561C1 |
Authors
Dates
2019-10-15—Published
2018-08-16—Filed